immunotherapy | Diversity of Non-Small Cell Lung Cancer Therapy
페이지 정보
Author HK HIS Date19-09-16 18:20 View900 Comment0첨부파일
-
Dong_et_al-2018-Journal_of_Evidence-Based_Medicine.pdf
(147.8K)
1 Download
DATE : 2019-06-24 14:38:30
관련링크
본문
CTLA-4 inhibitory treatment of T cells and lung cancer by PD-L1 inhibitor of cancer cells.
For many patients, CTLA-4 inhibitors, known as Yervoy,
PD-1 inhibitors such as Optivo and Keytruda.
